Bumper Offer - Urjas oil Just @ Rs. 1
Codep 37 is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Schizophrenia.
The right dosage of Codep 37 depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Codep 37 side effects, there are can be others also. These have been listed below. These side effects of Codep 37 are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Codep 37's effect during pregnancy is Moderate and Moderate while nursing. In addition, Codep 37's effects on the liver, heart and kidney are discussed below in the Codep 37 related warnings section.
Codep 37 is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease are examples of such conditions. Other conditions have been mentioned below in the Codep 37 contraindications section.
Additionally, Codep 37 may also adversely react with other medicines. See below for a complete list.
You should also be aware that Codep 37 is not safe while driving, and is not addiction.
Codep 37 is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Codep 37 is used -
Moderate
Mild
Is the use of Codep 37 safe for pregnant women?
Codep 37 can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Codep 37 right away. Take your doctor's advice before taking it again.
Is the use of Codep 37 safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Codep 37. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Codep 37 on the Kidneys?
Codep 37 may have mild side effects on the kidneys.
What is the effect of Codep 37 on the Liver?
Codep 37 may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Codep 37 on the Heart?
There is no research available on the side effects of Codep 37 on the heart. Therefore, its impact is unknown.
Codep 37 should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Codep 37 unless your doctor advises you to do so -
Is this Codep 37 habit forming or addictive?
You may get addicted to Codep 37. Therefore, before taking it, consult your doctor.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Codep 37. So it is best to avoid driving.
Is it safe?
Codep 37 should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, taking Codep 37 can treat mental disorders.
Interaction between Food and Codep 37
Due to a lack of research, nothing can be said about the consequences of taking Codep 37 together with food.
Interaction between Alcohol and Codep 37
Taking alcohol with Codep 37 can be dangerous.
Take Codep 37 1-4 times in a day or as advised by your doctor. It can be taken with or without food because the presence of food does not affect the absorption of this drug from the stomach. Precautions must be taken in patients with improper liver or kidney function.
Codep 37 contains chlordiazepoxide which works by calming the brain through increasing the activity of an inhibitory neurotransmitter GABA (gamma-aminobutyric acid) that decreases the abnormal brain activity which provides relief to the patient from anxiety and tension.
No, use of Codep 37 does not cause hair loss in the patients who are taking it. However, if you notice any unusual hair loss then consult it with your doctor.
Yes, Codep 37 is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as ataxia (which is lack of muscle coordination during voluntary movement), drowsiness, and confusion. If you experience above-mentioned side effects after taking this medicine then inform your doctor and follow his/her instructions.
Yes, Codep 37 can make you sleepy because it crosses the blood-brain barrier (a membrane that prevents the drugs from entering into the brain). After entering into the brain this drug calms the brain by increasing the activity of inhibitory neurotransmitter gamma-aminobutyric acid (GABA) that results in drowsiness. It is the most common side effect of this medicine. Activities such as driving and operating heavy machinery should be avoided after taking this Codep 37 to prevent accidents and injuries as it causes drowsiness.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Librium® C-IV (chlordiazepoxide HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 401-403
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 433
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Trihexyphenidyl Hydrochloride (trihexyphenidyl hydrochloride)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Artane (trihexyphenidyl hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 439-440
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 679-680
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 455-458
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tofranil-PM™ (imipramine pamoate)